Large-scale purification and single-dose oraltoxicity study of human thioredoxin and epidermal growth factor introduced into two different genetically modified soybean varieties = 형질전환 콩에 이용된 TRX와 EGF 단백질의 대량정제와 단회투여 독성평가
Cited 0 time in
- Large-scale purification and single-dose oraltoxicity study of human thioredoxin and epidermal growth factor introduced into two different genetically modified soybean varieties = 형질전환 콩에 이용된 TRX와 EGF 단백질의 대량정제와 단회투여 독성평가
- Jung-Ho Park
- Bibliographic Citation
- Korean Journal of Agricultural Science, vol. 48, no. 4, pp. 1003-1013
- Publication Year
- Thioredoxin (TRX) protein is an antioxidant responsible for reducing other proteins by exchanging cysteine thiol-disulfide and is also known for its anti-allergic and anti-aging properties. On the other hand, epidermal growth factor (EGF) is an important material used in the cosmetics industry and an essential protein necessary for dermal wound healing facilitated by the proliferation and migration of keratinocytes. EGF also assists in the formation of granulation tissues and stimulates the motility of fibroblasts. Hence, genetically modified soybeans were developed to overexpress these industrially important proteins for mass production. A single-dose oral-toxicity-based study was conducted to evaluate the potential toxic effects of TRX and EGF proteins, as safety assessments are necessary for the commercial use of seed-specific protein-expressing transgenic soybeans. To achieve this rationale, TRX and EGF proteins were mass purified from recombinant E. coli. The single-dose oraltoxicity tests of the TRX and EGF proteins were carried out in six-week old male and female Institute of Cancer Research (ICR) mice. The initial evaluation of the single-dose TRF and EGF treatments was based on monitoring the toxicity signatures and mortality rates among the mice, and the resultant mortality rates did not show any specific clinical symptoms related to the proteins. Furthermore, no significant differences were observed in the weights between the treatment and control groups of male and female ICR mice. After 14 days of treatment, no differences were observed in the autopsy reports between the various treatment and control groups. These results suggest that the minimum lethal dose of TRX and EGF proteins is higher than the allowed 2,000 mg·kg-1 limit.
- Epidermal growth factorGenetically modified soybeanICR (Institute of Cancer Research) miceSingle-dose toxicity studyThioredoxin
- Korea Soc-Assoc-Inst
- Appears in Collections:
- Division of Bio Technology Innovation > Bio-Evaluation Center > 1. Journal Articles
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.